|
|
||||||||
Division of Nuclear Medicine, Departments of Radiology and Pathology, Georgetown University Hospital, Washington, D.C.
Correspondence: For correspondence or reprints contact: Harvey A. Ziessman, MD. Georgetown University Hospital, Division of Nuclear Medicine, 3800 Reservoir Rd., NW, #2005 Gorman, Washington, DC 20007.
ABSTRACT
The purpose of this study was to evaluate the effect of P-glycoprotein (P-gp) levels, predominant histology and tumor size on the detectability of parathyroid adenomas with 99mTc-sestamibi scans. Although previous studies have shown that positivity correlates with tumor size, false-negative studies have been reported with large tumors and true-positives reported with very small tumors. Recent investigations have reported rapid washout of sestamibi in malignant tumors because of high levels of P-gp, similar to that seen with multidrug chemotherapy resistance. Therefore, we postulated that this mechanism might account for false-negative studies in parathyroid tumors. Preliminary reports have suggested that the predominant histological subtype influences positivity on 99mTc-sestamibi parathyroid scans. Methods: We studied 25 patients with surgically confirmed parathyroid adenomas with 99mTc-sestamibi parathyroid scans. The results of the imaging study were corralated with tissue P-gp levels, predominant histological subtype and size of the surgically removed glands. Results: There were 21 true-positive and 4 false-negative results. The size of the adenomas ranged from 0.12 to 8.64 ml. We found no correlation between the results of the dual-phase 99mTc-sestamibi study and either the predominant cell type or the level of P-gp. Positivity did correlate with the size of the adenoma (p = 0.73, p < 0.0001). We cannot exclude the possibility that P-gp and cell type may still play a role in individual cases, but we suspect that other yet to be determined factors may influence 99mTc-sestamibi detectability in addition to tumor size.
Key Words: parathyroid p-glycoprotein histology volume
This article has been cited by other articles:
![]() |
H. Takeuchi, N. C. Greep, D. S. B. Hoon, A. E. Giuliano, N. M. Hansen, N. Umetani, and F. R. Singer Hypermethylation of Adenosine Triphosphate-Binding Cassette Transporter Genes in Primary Hyperparathyroidism and Its Effect on Sestamibi Imaging J. Clin. Endocrinol. Metab., May 1, 2007; 92(5): 1785 - 1790. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Y. Mehta, J. M. Ruda, S. Kapadia, P. J. Boyer, C. S. Hollenbeak, and B. C. Stack Jr Relationship of Technetium Tc 99m Sestamibi Scans to Histopathological Features of Hyperfunctioning Parathyroid Tissue Arch Otolaryngol Head Neck Surg, June 1, 2005; 131(6): 493 - 498. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Ugur, M. F. Bozkurt, E. Hamaloglu, C. Sokmensuer, I. Etikan, Y. Ugur, I. Sayek, and S. A. Gulec Clinicopathologic and Radiopharmacokinetic Factors Affecting Gamma Probe-Guided Parathyroidectomy Arch Surg, November 1, 2004; 139(11): 1175 - 1179. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Kawata, M. Kanai, T. Sasada, S. Iwata, N. Yamamoto, and A. Takabayashi Usefulness of 99mTc-Sestamibi Scintigraphy in Suggesting the Therapeutic Effect of Chemotherapy against Gastric Cancer Clin. Cancer Res., June 1, 2004; 10(11): 3788 - 3793. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Mariani, S. A. Gulec, D. Rubello, G. Boni, M. Puccini, M. R. Pelizzo, G. Manca, D. Casara, G. Sotti, P. Erba, et al. Preoperative Localization and Radioguided Parathyroid Surgery J. Nucl. Med., September 1, 2003; 44(9): 1443 - 1458. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gorlick, A. C. Liao, C. Antonescu, A. G. Huvos, J. H. Healey, R. Sowers, M. Daras, E. Calleja, L. H. Wexler, D. Panicek, et al. Lack of Correlation of Functional Scintigraphy with 99mTechnetium-Methoxyisobutylisonitrile with Histological Necrosis following Induction Chemotherapy or Measures of P-Glycoprotein Expression in High-Grade Osteosarcoma Clin. Cancer Res., October 1, 2001; 7(10): 3065 - 3070. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| JOURNAL OF NUCLEAR MEDICINE TECHNOLOGY | THE JOURNAL OF NUCLEAR MEDICINE |